Ingles Markets to continue using McKesson Pharmacy Systems’ EnterpriseRx in pharmacies
ASHEVILLE, N.C. A regional grocery chain has extended its contract to use a pharmacy management system, operated by a subsidiary of McKesson Corp., in its stores’ pharmacies.
Ingles Markets said it would continue to use McKesson Pharmacy Systems-operated EnterpriseRx pharmacy management system. Ingles installed EnterpriseRx in 2006 and since has seen multiple operational improvements across its pharmacies, McKesson said. McKesson Pharmacy Systems’ EnterpriseRx is a fully integrated, software as a service pharmacy management suite. EnterpriseRx is designed with integrated workflow to provide multi-location users, such as Ingles, with broad control over the prescription filling process and workload along with administrative functionality for management. Through the centralized databases, EnterpriseRx also safeguards information, avoids many data consistency issues, and provides authorized users with real-time access to information from any location.
“We are committed to continuing our partnership with MPS because of their dedication to providing a state-of-the-art product,” said Steve Cucchi, VP pharmacy for Ingles. “MPS is driven by industry experts whom we trust to continue to deliver a product that helps us grow our business and keep us on course as the future of pharmacy and health care evolves.”
Added Stanton McComb, president of McKesson Pharmacy Systems, “Ingles encouraged its staff to utilize every aspect of EnterpriseRx and as a result they have become a solid development partner as we build future releases of EnterpriseRx.”
NACDS Foundation elects new board members
ALEXANDRIA, Va. The charitable arm of the National Association of Chain Drug Stores has appointed seven new members to its board of directors.
New members of the NACDS Foundation each will serve one-year term, the organization said. Newly elected NACDS Foundation board members include:
- Joseph W. Cavaliere, SVP customer development of Unilever;
- Debbie B. Garza, divisional VP government and community relations at Walgreens;
- William Graham, VP sales at Beiersdorf;
- David Klaum, general manager of Fougera and Nycomed US SVP;
- Louis J. Martire, VP trade development of Energizer Holdings;
- David A. Moules, VP channel development, patient assistance and reimbursement programs of GlaxoSmithKline; and,
- Robert Potter, SVP sales and marketing of Mylan Pharmaceuticals.
“The NACDS Foundation is dedicated to improving and advancing public health and wellness,” said NACDS Foundation president Edith A. Rosato. “Our board, which is truly representative of the pharmacy community –– from retailers and pharmaceutical companies to consumer product businesses –– shares in our commitment to education, research and charity. I applaud the pharmacy community’s support of the Foundation, welcome our new Board members, and look forward to working with them to implement the foundation’s vision and mission.”
Judge upholds patent for Protonix DR
JERUSALEM The U.S. District Court for the District of New Jersey has ruled that a patent covering a drug for gastroesophageal reflux disease is valid, Teva said.
A jury found that U.S. Patent No. 4,758,579, covering the drug Protonix DR (pantoprazole sodium) was valid, though a decision by the District Court judge independent of the jury’s verdict could still invalidate it.
Wyeth marketed the drug before its acquisition by Pfizer last year. Teva began shipping its generic version in December 2007.